voriconazole has been researched along with miltefosine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Farmen, S; Kaul, DR; Khaled, YA; Lowe, L; Visvesvara, GS; Yanik, GA | 1 |
| Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC | 1 |
| Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
| Bilbao, J; Duplisea, K; Guiot, MC; Kolyvas, G; Qvarnstrom, Y; Umar, I; Visvesvara, GS; Webster, D | 1 |
| Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X | 1 |
| Dannaoui, E; Datry, A; Fekkar, A; Imbert, S; Mazier, D; Meyer, I; Palous, M | 1 |
| Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C | 1 |
| Botterel, F; Bougnoux, ME; Compain, F; Dannaoui, E; Paugam, A; Sitterlé, E | 1 |
| Braga, SS | 1 |
| Barreto, TL; Ishida, K; Lopes, LB; Melo, AS | 1 |
| Bravo-Cossio, F; Cabello-Vilchez, AM; Carreazo, NY; Martínez, DY; Valdivia-Tapia, MDC | 1 |
| Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z | 1 |
1 review(s) available for voriconazole and miltefosine
| Article | Year |
|---|---|
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
12 other study(ies) available for voriconazole and miltefosine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
Topics: Acanthamoeba; Amebiasis; Animals; Antifungal Agents; Antiprotozoal Agents; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Phosphorylcholine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin; Triazoles; Voriconazole | 2008 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2009 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.
Topics: Acanthamoeba; Adult; Amebiasis; Animals; Encephalitis; Granuloma; Humans; Immunocompetence; Male; Military Personnel; Phosphorylcholine; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro combination of voriconazole and miltefosine against clinically relevant molds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fusariosis; Fusarium; Microbial Sensitivity Tests; Phosphorylcholine; Scedosporium; Voriconazole | 2014 |
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2015 |
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Scedosporium; Voriconazole | 2015 |
Topics: Alginates; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Drug Carriers; Drug Synergism; Nanoparticles; Phosphorylcholine; Voriconazole | 2021 |
Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole.
Topics: Amebiasis; Central Nervous System Protozoal Infections; Child; Humans; Naegleria; Naegleria fowleri; Phosphorylcholine; Voriconazole | 2022 |
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |